Virax Biolabs Group Limited Ordinary Shares
Quarterly Financials
| Values in thousands | 2026-06-30 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
Revenue | $10 | $1 | $1 |
Gross Profit | 223 | -215 | -46 |
EBITDA | -3,678 | -2,369 | -3,139 |
EBIT | -3,813 | -2,585 | -3,284 |
Net Income | -2,684 | -2,338 | -3,304 |
Net Change In Cash | 10 | 1 | 1 |
Free Cash Flow | -1,975 | -3,064 | -3,000 |
Cash | 6,438 | 3,345 | 4,228 |
Basic Shares | 604 | 190 | 174 |
Annual Financials
| Values in thousands | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
Revenue | $12 | $6 | $156 | $8 |
Gross Profit | 7 | -53 | 50 | -1 |
EBITDA | -6,048 | -5,802 | -6,609 | -5,442 |
EBIT | -6,399 | -6,145 | -6,712 | -5,442 |
Net Income | -5,023 | -6,061 | -6,733 | -5,457 |
Net Change In Cash | 12 | 6 | 156 | 8 |
Free Cash Flow | -4,877 | -5,167 | -7,411 | -4,358 |
Cash | 6,438 | 4,228 | 3,589 | 9,352 |
Basic Shares | 397 | 124 | 80 | 42 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.49 |
2025-06-30 | -$0.76 |
2024-09-30 | -$0.89 |
2022-06-30 | -$0.03 |